Impact fact

Josh has supported product development, launch and portfolio strategy in 40-plus disease areas with more than a dozen pharma and medical device companies.


Josh is part of ZS’s pipeline and launch strategy practice, leading the Philadelphia-based team within the practice as well as ZS’s portfolio strategy service line.




Josh’s focus is in helping pharmaceutical companies develop strategies for product development and commercialization. His passion is the intersection of science and business, helping clients develop cross-functional strategies for their products and portfolios as well as capabilities that bridge commercial, medical and clinical. He specializes in cross-functional challenges such as market mapping and market shaping, portfolio prioritization, market segmentation, value proposition development and evidence generation strategy.  



Prior experience

Josh’s past experience includes a digital business intelligence startup where he covered the consumer packaged goods sector, corporate strategy for a Fortune 500 mining company, and consulting within the U.S. federal government.




Josh holds an MBA from the University of Virginia’s Darden School of Business with a concentration in corporate finance. He also received a B.A in political science from American University and completed the general course programme at the London School of Economics.



Media coverage